Page last updated: 2024-08-24

fosphenytoin and Local Neoplasm Recurrence

fosphenytoin has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kandasamy, S; Krishnamoorthi, N; Nalisetty, S; Sangaralingam, T; Sridharan, B; Vijayakumar, V1
Asami, M; Egawa, S; Hoshiyama, E; Inoue, Y; Kaneko, J; Kimura, A; Kondo, Y; Maruo, K; Marushima, A; Nakamura, K; Takahashi, Y; Yamada, T; Yonekawa, C1

Trials

2 trial(s) available for fosphenytoin and Local Neoplasm Recurrence

ArticleYear
Clinical Effectiveness of Levetiracetam Compared to Fosphenytoin in the Treatment of Benzodiazepine Refractory Convulsive Status Epilepticus.
    Indian journal of pediatrics, 2020, Volume: 87, Issue:7

    Topics: Anticonvulsants; Benzodiazepines; Child; Humans; Levetiracetam; Neoplasm Recurrence, Local; Phenytoin; Status Epilepticus; Treatment Outcome

2020
Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
    Trials, 2021, May-02, Volume: 22, Issue:1

    Topics: Adult; Anticonvulsants; Diazepam; Humans; Japan; Levetiracetam; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Phenytoin; Randomized Controlled Trials as Topic; Status Epilepticus; Treatment Outcome

2021